Literature DB >> 27859590

Miz-1 and Max compete to engage c-Myc: implication for the mechanism of inhibition of c-Myc transcriptional activity by Miz-1.

Mikaël Bédard1,2,3, Loïka Maltais1,2,3, Martin Montagne1,2,3, Pierre Lavigne1,2,3.   

Abstract

c-Myc is a basic helix-loop-helix leucine zipper (b-HLH-LZ) transcription factor deregulated in the majority of human cancers. As a heterodimer with Max, another b-HLH-LZ transcription factor, deregulated and persistent c-Myc accumulates at transcriptionally active promoters and enhancers and amplifies transcription. This leads to the so-called transcriptional addiction of tumor cells. Recent studies have showed that c-Myc transcriptional activities can be reversed by its association with Miz-1, a POZ transcription factor containing 13 classical zinc fingers. Although evidences have led to suggest that c-Myc interacts with both Miz-1 and Max to form a ternary repressive complex, earlier evidences also suggest that Miz-1 and Max may compete to engage c-Myc. In such a scenario, the Miz-1/c-Myc complex would be the entity responsible for the inhibition of c-Myc transcriptional amplification. Considering the implications of the Miz-1/c-Myc interaction, it is highly important to solve this duality. While two potential c-Myc interacting domains (hereafter termed MID) have been identified in Miz-1 by yeast two-hybrid, with the b-HLH-LZ as a bait, the biophysical characterization of these interactions has not been reported so far. Here, we report that the MID located between the 12th and 13th zinc finger of Miz-1 and the b-HLH-LZ of Max compete to form a complex with the b-HLH-LZ of c-Myc. Our results support the notion that the repressive action of Miz-1 on c-Myc does not rely on the formation of a ternary complex. The implications of these observations for the mechanism of inhibition of c-Myc transcriptional activity by Miz-1 are discussed. Proteins 2017; 85:199-206.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Max; Miz-1; NMR; b-HLH-LZ; c-Myc; circular dichroism

Mesh:

Substances:

Year:  2016        PMID: 27859590     DOI: 10.1002/prot.25214

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  2 in total

Review 1.  Blocking Myc to Treat Cancer: Reflecting on Two Decades of Omomyc.

Authors:  Daniel Massó-Vallés; Laura Soucek
Journal:  Cells       Date:  2020-04-04       Impact factor: 6.600

2.  Radiosensitizing effects of c‑myc gene knockdown‑induced G2/M phase arrest by intrinsic stimuli via the mitochondrial signaling pathway.

Authors:  Yunpeng Fan; Xiaofeng Jia; Tao Xie; Liulong Zhu; Fan He
Journal:  Oncol Rep       Date:  2020-10-13       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.